Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Sotera Health (SHC) EPS (Weighted Average and Diluted) (2020 - 2025)

Sotera Health (SHC) has 6 years of EPS (Weighted Average and Diluted) data on record, last reported at $0.12 in Q4 2025.

  • For Q4 2025, EPS (Weighted Average and Diluted) rose 140.0% year-over-year to $0.12; the TTM value through Dec 2025 reached $0.27, up 68.75%, while the annual FY2025 figure was $0.27, 68.75% up from the prior year.
  • EPS (Weighted Average and Diluted) reached $0.12 in Q4 2025 per SHC's latest filing, down from $0.17 in the prior quarter.
  • Across five years, EPS (Weighted Average and Diluted) topped out at $0.17 in Q3 2025 and bottomed at -$1.14 in Q4 2022.
  • Average EPS (Weighted Average and Diluted) over 5 years is $0.01, with a median of $0.07 recorded in 2023.
  • Peak YoY movement for EPS (Weighted Average and Diluted): surged 3594.75% in 2021, then plummeted 1050.0% in 2022.
  • A 5-year view of EPS (Weighted Average and Diluted) shows it stood at $0.12 in 2021, then plummeted by 1050.0% to -$1.14 in 2022, then surged by 112.28% to $0.14 in 2023, then plummeted by 64.29% to $0.05 in 2024, then surged by 140.0% to $0.12 in 2025.
  • Per Business Quant database, its latest 3 readings for EPS (Weighted Average and Diluted) were $0.12 in Q4 2025, $0.17 in Q3 2025, and $0.03 in Q2 2025.